Cargando…

Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma

BACKGROUND: Melanoma is an extremely aggressive type of skin cancer and experiencing a expeditiously rising mortality in a current year. Exploring new potential prognostic biomarkers and therapeutic targets of melanoma are urgently needed. The ambition of this research was to identify genetic marker...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jinfang, Zhou, Zijian, Ma, Ling, Li, Chujun, Lin, Yu, Yu, Ting, Wei, Ji-Fu, Zhu, Lingjun, Yao, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393813/ https://www.ncbi.nlm.nih.gov/pubmed/34446007 http://dx.doi.org/10.1186/s12935-021-02163-9

Ejemplares similares

Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression
por: He, Rong-Zhang, et al.
Publicado: (2021)

Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma
por: Liu, Jinfang, et al.
Publicado: (2022)

DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups
por: Tian, Zijian, et al.
Publicado: (2020)

N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma
por: Zhao, Yibin, et al.
Publicado: (2022)

Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression
por: Zheng, Qing-Kang, et al.
Publicado: (2021)

The value of melanoma inhibitory activity and LDH with melanoma patients in a Chinese population
por: Li, Chujun, et al.
Publicado: (2021)

Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer
por: Ma, Jian, et al.
Publicado: (2021)

ERBB3 binding protein 1 promotes the progression of malignant melanoma through activation of the Wnt/ β-catenin signaling pathway
por: Bao, Yanqiu, et al.
Publicado: (2022)

Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAs
por: Han, Tenghui, et al.
Publicado: (2021)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

N(6)-methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma
por: Zheng, Zongtai, et al.
Publicado: (2020)

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
por: Liu, Chi, et al.
Publicado: (2022)

N(6)-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma
por: Zheng, Xin, et al.
Publicado: (2023)

The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies
por: Zhao, Yan, et al.
Publicado: (2022)

Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients
por: Huang, Biao, et al.
Publicado: (2020)

N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer
por: Wu, Qunying, et al.
Publicado: (2021)

High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer
por: Yao, Ling, et al.
Publicado: (2019)

N6-methyladenosine methylation in kidney injury
por: Wang, Qimeng, et al.
Publicado: (2023)

Circular RNA circRNA_0082835 promotes progression and lymphatic metastasis of primary melanoma by sponging microRNA miRNA-429
por: Sun, Yute, et al.
Publicado: (2021)

UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer
por: Zhao, Ya-li, et al.
Publicado: (2019)

Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
por: Gao, Chundi, et al.
Publicado: (2018)

Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
por: Wang, Shanshan, et al.
Publicado: (2021)

Identification of a m(6)A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
por: Chen, Jing, et al.
Publicado: (2020)

Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis
por: Yamamoto, Yosuke, et al.
Publicado: (2020)

Selective growth inhibition of human malignant melanoma cells by syringic acid-derived proteasome inhibitors
por: Orabi, Khaled Y, et al.
Publicado: (2013)

BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020)

SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways
por: Wang, Xizhao, et al.
Publicado: (2019)

High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer
por: Zhao, Zongxian, et al.
Publicado: (2021)

DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups
por: Chen, Wenbiao, et al.
Publicado: (2019)

Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis
por: Liu, JinHui, et al.
Publicado: (2019)

Action of Lovastatin (Mevinolin) on an in vitro model of angiogenesis and its co-culture with malignant melanoma cell lines
por: Depasquale, Ivan, et al.
Publicado: (2006)

TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination
por: Chen, Jia-xin, et al.
Publicado: (2021)

Comprehensive analysis of N(6)-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer
por: Cui, Jianfeng, et al.
Publicado: (2022)

The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2019)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

Increased expression of Six1 correlates with progression and prognosis of prostate cancer
por: Zeng, Jun, et al.
Publicado: (2015)

Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro
por: Lou, Weiyang, et al.
Publicado: (2020)

Contribution of nestin positive esophageal squamous cancer cells on malignant proliferation, apoptosis, and poor prognosis
por: Zhong, Beilong, et al.
Publicado: (2014)

Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer
por: Yu, Jing, et al.
Publicado: (2021)

Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients
por: Zheng, Xinyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_faleg7i205her6hgm0dq9eiq99